AUT00206, a novel Kv3 channel modulator, reduces ketamine-induced BOLD signalling in healthy male volunteers: a randomised placebo-controlled crossover trial
AUT00206, a novel Kv3 channel modulator, reduces ketamine-induced BOLD signalling in healthy male volunteers: a randomised placebo-controlled crossover trial
SIRS, 2019
Deakin et al
Download Poster (1.5 MB)